|Articles|July 20, 2023
How Can Phase I Data from the West Accelerate Drug Development in China and Japan? The Science and Practice of Ethnobridging
Author(s)PAREXEL
There is great value in global, multi-ethnic approaches to early-phase drug development, and they can accelerate the availability of new therapies in Asia.
Trending on Applied Clinical Trials Online
1
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
2
ACT Brief: Real-Time Trial Infrastructure Gaps, Built-In Data Security, and AI-Enabled CDMO Value
3
Real-Time Clinical Trials: What the FDA's Push Toward Continuous Oversight Means for Sponsors
4
ACT Brief: DIA Leadership and Infrastructure Priorities, Real-Time Data Review Readiness, and CLL Treatment Expansion
5